Because different studies that investigated the effect of hCG in cancer cells, including the breast cancer cell line MCF7, have reported controversial results [26], we hypothesized that the presence of serum, which generally contains LH and FSH, in the culture medium may influence cell response to the exogenous administration of hCG. The gene discussed is PLOD1; the disease is breast cancer.